QFT-Plus is a blood-based test that only requires a single visit and is unaffected by prior BCG vaccination, whereas traditional skin tests require two visits and can yield false positives in vaccinated individuals.

The QFT-Plus test is effective in detecting TB infection but does not distinguish between latent and active TB. Additional diagnostic procedures, such as imaging and sputum analysis, are required to confirm active TB.

A positive result means that TB bacteria may be present. Your healthcare provider will recommend further tests to confirm if the infection is active and to determine the appropriate treatment plan.

The QFT-Plus test has high specificity and sensitivity, minimizing false positives and negatives. It is considered one of the most reliable methods for TB screening.

Yes, QFT-Plus is recommended over TB skin tests, especially for high-risk populations and those who have been vaccinated with BCG.